Literature DB >> 25364507

Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles.

K K Pohaku Mitchell1, S Sandoval2, M J Cortes-Mateos3, J G Alfaro4, A C Kummel1, W C Trogler1.   

Abstract

Iron(III)-doped silica nanoshells are shown to possess an in vitro cell-receptor mediated targeting functionality for endocytosis. Compared to plain silica nanoparticles, iron enriched ones are shown to be target-specific, a property that makes them potentially better vehicles for applications, such as drug delivery and tumor imaging, by making them more selective and thereby reducing the nanoparticle dose. Iron(III) in the nanoshells can interact with endogenous transferrin, a serum protein found in mammalian cell culture media, which subsequently promotes transport of the nanoshells into cells by the transferrin receptor-mediated endocytosis pathway. The enhanced uptake of the iron(III)-doped nanoshells relative to undoped silica nanoshells by a transferrin receptor-mediated pathway was established using fluorescence and confocal microscopy in an epithelial breast cancer cell line. This process was also confirmed using fluorescence activated cell sorting (FACS) measurements that show competitive blocking of nanoparticle uptake by added holo-transferrin.

Entities:  

Keywords:  Silica; nanoparticles; nanoshells; self-targeting; transferrin

Year:  2014        PMID: 25364507      PMCID: PMC4214387          DOI: 10.1039/C4TB01429D

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  74 in total

1.  Enhancing surface interactions with colon cancer cells on a transferrin-conjugated 3D nanostructured substrate.

Authors:  Shashwat S Banerjee; Debjani Paul; Sujit G Bhansali; Naval D Aher; Archana Jalota-Badhwar; Jayant Khandare
Journal:  Small       Date:  2012-03-21       Impact factor: 13.281

2.  Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.

Authors:  Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Liangfang Zhang
Journal:  Nanoscale       Date:  2013-11-26       Impact factor: 7.790

3.  The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.

Authors:  M P Desai; V Labhasetwar; E Walter; R J Levy; G L Amidon
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

4.  Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.

Authors:  Michael E Werner; Shrirang Karve; Rohit Sukumar; Natalie D Cummings; Jonathan A Copp; Ronald C Chen; Tian Zhang; Andrew Z Wang
Journal:  Biomaterials       Date:  2011-08-16       Impact factor: 12.479

5.  Hollow silica and silica-boron nano/microparticles for contrast-enhanced ultrasound to detect small tumors.

Authors:  Alexander Liberman; H Paul Martinez; Casey N Ta; Christopher V Barback; Robert F Mattrey; Yuko Kono; Sarah L Blair; William C Trogler; Andrew C Kummel; Zhe Wu
Journal:  Biomaterials       Date:  2012-04-11       Impact factor: 12.479

6.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

7.  Recent advances in cancer research: drug targeting without the use of monoclonal antibodies.

Authors:  W P Faulk; H Harats; J A McIntyre; A Berczi; I L Sun; F L Crane
Journal:  Am J Reprod Immunol       Date:  1989 Nov-Dec       Impact factor: 3.886

8.  Transferrin receptor 2 is frequently expressed in human cancer cell lines.

Authors:  Alessia Calzolari; Isabella Oliviero; Silvia Deaglio; Gualtiero Mariani; Mauro Biffoni; Nadia Maria Sposi; Fabio Malavasi; Cesare Peschle; Ugo Testa
Journal:  Blood Cells Mol Dis       Date:  2007-04-10       Impact factor: 3.039

9.  Programmable cellular retention of nanoparticles by replacing the synergistic anion of transferrin.

Authors:  Li-Chen Wu; Li-Wei Chu; Leu-Wei Lo; Yen-Chen Liao; Yu-Chao Wang; Chung-Shi Yang
Journal:  ACS Nano       Date:  2012-12-10       Impact factor: 15.881

10.  Dual-porosity hollow nanoparticles for the immunoprotection and delivery of nonhuman enzymes.

Authors:  Inanc Ortac; Dmitri Simberg; Ya-san Yeh; Jian Yang; Bradley Messmer; William C Trogler; Roger Y Tsien; Sadik Esener
Journal:  Nano Lett       Date:  2014-02-06       Impact factor: 11.189

View more
  1 in total

Review 1.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.